Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
about
Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.Human papillomavirus infection in 674 Chinese patients with laryngeal squamous cell carcinomaEpigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPV-positive oropharyngeal squamous cell carcinomaHeterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.Detection of HPV in oral rinse samples from OPSCC and non-OPSCC patients.The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategiesp53 expression but not p16(INK4A) correlates with human papillomavirus-associated esophageal squamous cell carcinoma in Kazakh populationPrevalence of human papillomavirus types and variants and p16(INK4a) expression in head and neck squamous cells carcinomas in São Paulo, Brazil.Human Papillomavirus Infections are Common and Predict Mortality in a Retrospective Cohort Study of Taiwanese Patients With Oral Cavity Cancer.Expression of the extracellular sulfatase SULF2 is associated with squamous cell carcinoma of the head and neckNonpromoter methylation of the CDKN2A gene with active transcription is associated with improved locoregional control in laryngeal squamous cell carcinoma.PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinomaCharacterization of key transcription factors as molecular signatures of HPV-positive and HPV-negative oral cancers.Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status.Effect of postoperative radiotherapy in pT1pN1cM0 and pT2p/cN0cM0 oropharyngeal squamous cell carcinoma.Detection of human papillomavirus in laryngeal squamous cell carcinoma: Systematic review and meta-analysis.Protocol: systematic review of the association between socio-economic status and survival in adult head and neck cancer.Matched computed tomography segmentation and demographic data for oropharyngeal cancer radiomics challenges.HPV Testing of Head and Neck Cancer in Clinical Practice.p16INK4a : A surrogate marker of high-risk human papillomavirus infection in squamous cell carcinoma of the nasal vestibule.Copy number gain of 11q13.3 genes associates with pathological stage in hypopharyngeal squamous cell carcinoma.Human papillomavirus and oropharyngeal squamous cell carcinoma: a New Zealand cohort study.Cancer as the Disintegration of Robustness: Population-Level Variance in Gene Expression Identifies Key Differences Between Tobacco- and HPV-Associated Oropharyngeal Carcinogenesis.Effect of HPV on tumor expression levels of the most commonly used markers in HNSCC.P16(INK⁴a) overexpression is associated with CDKN2A mutation and worse prognosis in HPV-negative laryngeal squamous cell carcinomas.Increased p16 and p53 protein expression predicts poor prognosis in mucosal melanoma.Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.Meta analysis: HPV and p16 pattern determines survival in patients with HNSCC and identifies potential new biologic subtype.Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma.PD-L1 expression is associated with p16INK4A expression in non-oropharyngeal head and neck squamous cell carcinoma.Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers.Reliability and a correlational analysis of the 6MWT, ten-meter walk test, thirty second sit to stand, and the linear analog scale of function in patients with head and neck cancer.The prognostic value of HPV combined p16 status in patients with anal squamous cell carcinoma: a meta-analysis.
P2860
Q30241076-E233FEBF-93B4-4195-A83A-1D8A281E35DDQ34764776-0BB957A7-86F4-4A49-81C6-789AD9E68D0CQ35236773-986D9BF2-605C-4676-9054-01E39F581DADQ35756750-EF4CC869-A4AE-41D7-95B4-BECF942736D7Q35809812-54707472-8978-42A3-ADA8-1B465D2668A7Q35838231-6309E688-598D-4DEB-A8E3-0889CE0DAC14Q36793596-5F365054-4293-4B88-916F-DBB7BE450E69Q36865275-D783F655-64B6-4566-AE13-C5AAF3FEB46DQ37328581-831F6C52-8EAC-4B7D-9EC4-00114E713F3EQ37536514-0D33C6FA-3F8E-4D51-B699-4440F1EBC7E0Q37648149-95EFB4A6-13C4-4027-AB07-F1999A536CFEQ37689028-5050DA75-2551-4C4F-BC56-8EB91AFF0EC6Q37693385-F0A0632B-6720-438C-9A18-7479E98D4144Q38557897-78A3E422-AEC2-48E1-AEC9-A2963D71E430Q38612314-2CCBA3D4-7697-4E76-9F7C-0EA49F18840CQ38626463-735E7716-0EEE-4B70-B3F9-4C64661730ADQ38646232-92A6700B-E8D9-4DA4-B69C-E2D5EED8262EQ38694676-77F4DA69-4090-480A-AFA2-51F784152392Q38971546-29F0F5A6-5003-49CC-886D-50E55017BA70Q40260945-C969CFFE-F2D1-4D85-B988-BE21E3810BBAQ40503694-7ABB205F-7837-4DFB-ACB1-452400AB2A08Q40534462-B3A64CE5-2FC4-432E-8A6C-A350DD91B70CQ40778155-0741C26B-2AC6-4BB2-9A5E-32B1C2BDE1FAQ40871740-BA7C9406-DED9-4C26-B2C6-E2ABF1B1ED80Q41503135-669AA679-BDC9-4AC4-A63F-A271526A0FF0Q41593112-FFF1A008-CF8A-41E6-B75E-4AEF8D84EBC1Q42217974-C80ADDBB-B219-4BA3-BA4F-51ED2B11E0DBQ47106465-06BD0AE4-9B0D-4319-A9C6-75AE77CAC1ECQ49925064-B4F49F19-AD47-4562-9C46-0F93FF979086Q50003278-CDE693BA-8F10-4988-926F-E2DFEDCF7A92Q50045845-97A343F4-F676-44F0-83DF-A3A81E2A8ADDQ50081428-D7D0223A-CE16-44F1-B605-DD6A4CA7AE38Q50322944-0802D1DD-2F68-4050-9D98-5E7A936DF9AC
P2860
Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
@ast
Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
@en
Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
@nl
type
label
Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
@ast
Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
@en
Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
@nl
prefLabel
Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
@ast
Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
@en
Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
@nl
P2093
P2860
P356
P1476
Combined P16 and human papillomavirus testing predicts head and neck cancer survival
@en
P2093
Bradley A Schiff
Jordan Elman
Madhur Garg
Michael B Prystowsky
Nicolas F Schlecht
Nicole Anayannis
Nicole Kawachi
Richard V Smith
Robert D Burk
Thomas J Belbin
P2860
P304
P356
10.1002/IJC.28876
P577
2014-04-17T00:00:00Z